The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
Primary Purpose
Hypertension
Status
Completed
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Levobupivacaine
Bupivacaine
placebo
Sponsored by

About this trial
This is an interventional treatment trial for Hypertension focused on measuring anaesthesia, local anaesthesia, hemodynamics, bupivacaine, levobupivacaine
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) Physical Status classification system 1-2
Exclusion Criteria:
- Uncontrolled hypertension, arrhythmia, diabetes mellitus or coagulopathy, coronary artery disease or a proven or suspected allergy to bupivacaine or levobupivacaine
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Active Comparator
Arm Label
bupivacaine,levobupivacaine
levobupivacaine
bupivacaine
Arm Description
20 ml of 0.5% bupivacaine 20 ml of 0.5% levobupivacaine
20 ml of 0.5% levobupivacaine saline as a placebo
20 ml of 0.5% bupivacaine saline as a placebo
Outcomes
Primary Outcome Measures
Change in Mean Arterial Pressure
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02497040
Brief Title
The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
Official Title
Effects of Scalp Block With Bupivacaine Versus Levobupivacaine on Haemodynamic Response to Head Pinning and Efficacy on Postoperative Analgesia
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
March 2008 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
April 2009 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Uludag University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Ninety American Society of Anesthesiologists (ASA) Physical Status classification system I-II patients were recruited for a randomised, placebo-controlled, double-blind study and were randomly divided into three groups to receive either 20 ml of 0.5% bupivacaine (Group B; n=30), 20 ml of 0.5% levobupivacaine (Group L; n=30) or saline as a placebo (Group C; n=30). Scalp block was performed 5 min before head pinning. The primary outcome of the study was mean arterial pressure (MAP) and secondary outcomes were heart rate (HR), visual analogue scale (VAS) scores, additional intraoperative and postoperative drug use. Postoperative pain was evaluated using a 10-cm visual analogue scale (VAS).
Detailed Description
Following approval from the Research Ethics Committee of the Medical Faculty of Uludağ University, (the date and protocol number assigned by this ethics committee were March 4, 2008 and 5/30, respectively),written informed consent was obtained from patients undergoing elective scheduled operations involving craniotomy during anaesthesia consultations. Ninety American Society of Anesthesiologists (ASA) Physical Status classification system I or II patients of either sex between 18-85 years of age were allocated to this randomised, prospective, placebo-controlled, double-blind study. The patients were randomly divided into three groups using a sealed-enveloped technique to receive either 20 ml of 0.5% bupivacaine (Group B (n=30)), 20 ml of 0.5% levobupivacaine (Group L (n=30)) or saline as a placebo (Group C (n=30)). Twenty-millilitre syringes for the block were prepared and numbered by a blinded assistant.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
anaesthesia, local anaesthesia, hemodynamics, bupivacaine, levobupivacaine
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare Provider
Allocation
Randomized
Enrollment
90 (Actual)
8. Arms, Groups, and Interventions
Arm Title
bupivacaine,levobupivacaine
Arm Type
Experimental
Arm Description
20 ml of 0.5% bupivacaine 20 ml of 0.5% levobupivacaine
Arm Title
levobupivacaine
Arm Type
Active Comparator
Arm Description
20 ml of 0.5% levobupivacaine saline as a placebo
Arm Title
bupivacaine
Arm Type
Active Comparator
Arm Description
20 ml of 0.5% bupivacaine saline as a placebo
Intervention Type
Drug
Intervention Name(s)
Levobupivacaine
Other Intervention Name(s)
chirocaine
Intervention Description
local injection
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Other Intervention Name(s)
marcaine
Intervention Description
local injection
Intervention Type
Drug
Intervention Name(s)
placebo
Other Intervention Name(s)
saline
Intervention Description
local injection
Primary Outcome Measure Information:
Title
Change in Mean Arterial Pressure
Time Frame
220+-70 minutes
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
American Society of Anesthesiologists (ASA) Physical Status classification system 1-2
Exclusion Criteria:
Uncontrolled hypertension, arrhythmia, diabetes mellitus or coagulopathy, coronary artery disease or a proven or suspected allergy to bupivacaine or levobupivacaine
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
hulya bilgin
Organizational Affiliation
uludag university anaesthesia and reanimation department
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
8942596
Citation
Pinosky ML, Fishman RL, Reeves ST, Harvey SC, Patel S, Palesch Y, Dorman BH. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec;83(6):1256-61. doi: 10.1097/00000539-199612000-00022.
Results Reference
background
PubMed Identifier
11426091
Citation
Agarwal A, Sinha PK, Pandey CM, Gaur A, Pandey CK, Kaushik S. Effect of a subanesthetic dose of intravenous ketamine and/or local anesthetic infiltration on hemodynamic responses to skull-pin placement: a prospective, placebo-controlled, randomized, double-blind study. J Neurosurg Anesthesiol. 2001 Jul;13(3):189-94. doi: 10.1097/00008506-200107000-00002.
Results Reference
background
PubMed Identifier
15817709
Citation
Costello TG, Cormack JR, Mather LE, LaFerlita B, Murphy MA, Harris K. Plasma levobupivacaine concentrations following scalp block in patients undergoing awake craniotomy. Br J Anaesth. 2005 Jun;94(6):848-51. doi: 10.1093/bja/aei135. Epub 2005 Apr 7.
Results Reference
background
Learn more about this trial
The Effects of Scalp Block With Bupivacaine Versus Levobupivacaine
We'll reach out to this number within 24 hrs